Orthopedic Surgery Doctors in Sonora, CA Accepting Medicare

5 Orthopedic Surgery doctors found. Showing 1 - 5

Mr. Thomas James Mcdonald, M.D. Orthopaedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 680 Guzzi Lane, Suite 105, Sonora, CA 95370 Phone: 209-532-0126    Fax: 209-532-2950

Dr. James Ivy Boyd Iii, MD Orthopaedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 680 Guzzi Ln Ste 105, Sonora, CA 95370 Phone: 209-532-0126    Fax: 209-532-2950

Dr. Airell Leighton Nygaard, M.D. Orthopaedic Surgery Medicare: Medicare Enrolled Practice Location: 680 Guzzi Ln, Suite 102, Sonora, CA 95370 Phone: 209-588-1800    Fax: 209-588-1700

Ariana Marie Demers, D.O. Orthopaedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 13949 Mono Way, Sonora, CA 95370 Phone: 209-533-5371

Dr. John Patrick Nelligan Iii, MD Orthopaedic Surgery - Sports Medicine Medicare: Accepting Medicare Assignments Practice Location: 680 Guzzi Ln Ste 102, Sonora, CA 95370 Phone: 209-536-5780    Fax: 209-588-2760

News Archive

Distress and fatigue among medical residents can lead to significant risk of medical error: Study

Mayo Clinic researchers report that distress and fatigue among medical residents are independent contributors to self-perceived medical errors. The findings appear today in the Journal of the American Medical Association (JAMA).

Rosiglitazone therapy associated with increased risk for heart attack: Study

Eleven years after the introduction of the diabetes drug rosiglitazone, data from available clinical trials demonstrate an increased risk for heart attack associated with its use and suggest an unfavorable benefit-to-risk ratio, according to a report posted online today that will appear in the July 26 print issue of Archives of Internal Medicine, one of the JAMA/Archives journals.

FDA approves the New Drug Application for Pennsaid Topical Solution

Covidien, a leading global provider of healthcare products, and Nuvo Research Inc., a Canadian drug development company, today announced that the U.S. Food and Drug Administration (FDA) has approved the New Drug Application for Pennsaid(R) Topical Solution (diclofenac sodium topical solution) 1.5% w/w.

International Federation of Red Cross and Red Crescent Societies and Coca-Cola enter global partnership

Coca-Cola Hellenic has welcomed the opportunity to build upon its disaster response programme and community development projects across its 28 countries following the signing of a partnership agreement between the International Federation of Red Cross and Red Crescent Societies (IFRC) and The Coca-Cola Company (TCCC).

Read more Medical News

› Verified 9 days ago